I
IMCC
vs
S&P 500
S&P 500
Over the past 12 months, IMCC has underperformed S&P 500, delivering a return of -36% compared to the S&P 500's +16% growth.
Stocks Performance
IMCC vs S&P 500
Performance Gap
IMCC vs S&P 500
Performance By Year
IMCC vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
IM Cannabis Corp
Glance View
IM Cannabis Corp. engages in the production and sale of medical cannabis products. The company is headquartered in Vancouver, British Columbia and currently employs 283 full-time employees. The firm operates in Israel through its commercial relationship with Focus Medical Herbs Ltd. (Focus Medical), where it cultivates, imports and distributes cannabis to medical patients, data and patient insights. The firm also operates medical cannabis retail pharmacies, online platforms, distribution centers and logistical hubs in Israel. The firm operates in Germany through Adjupharm GmbH (Adjupharm), where it is a certified medical cannabis producer and distributor with wholesale, narcotics handling, manufacturing, procurement, storage, and distribution licenses. The firm operates in Canada through Trichome JWC Acquisition Corp. d/b/a JWC and MYM Nutraceuticals Inc., where it cultivates and processes cannabis for the adult-use market at its Ontario and Nova Scotia facilities under the WAGNERS and Highland Grow brands.
